High-potency cannabis linked to serious mental health risks in youth

This scoping review examined 71 studies investigating how cannabis potency relates to mental health outcomes in adolescents and young adults aged 14-25. The research revealed a critical finding: high-potency cannabis (>15% THC) is significantly more strongly associated with severe mental health issues compared to lower-potency products. Specifically, researchers found increased risks of cannabis dependence, psychosis, and cognitive deficits among those using potent cannabis products. This matters because cannabis potency has been rising dramatically worldwide, creating a shift in what today's youth are consuming compared to previous generations.

The study identified that the magnitude and number of adverse mental health outcomes increase substantially with higher THC concentrations. Adolescents and young adults represent a particularly vulnerable population since their brains are still developing during this critical period. The research underscores an important gap: most cannabis studies haven't adequately measured or controlled for potency when investigating mental health effects, which means previous research may have underestimated the true risks associated with high-potency products.

The authors argue that future cannabis research must systematically measure and report product potency, and they recommend that policymakers consider potency levels when developing cannabis regulations. This scoping review provides evidence-based guidance for both researchers and regulators trying to understand and address the evolving cannabis landscape, particularly as it affects the mental health of younger users during critical neurodevelopmental stages.